HomeCompareSYK vs ROL

SYK vs ROL: Dividend Comparison 2026

SYK yields 1.04% · ROL yields 1.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ROL wins by $14.13M in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ROL
ROL
● Live price
1.38%
Share price
$53.04
Annual div
$0.73
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$14.17M
Annual income
$12,435,164.79
Full ROL calculator →

Portfolio growth — SYK vs ROL

📍 ROL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKROL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ROL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ROL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ROL
Annual income on $10K today (after 15% tax)
$116.99/yr
After 10yr DRIP, annual income (after tax)
$10,569,890.07/yr
At 15% tax rate, ROL beats the other by $10,562,849.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ROL for your $10,000?

SYK: 50%ROL: 50%
100% ROL50/50100% SYK
Portfolio after 10yr
$7.11M
Annual income
$6,221,723.88/yr
Blended yield
87.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ROL
Analyst Ratings
8
Buy
9
Hold
Consensus: Hold
Price Target
$64.00
+20.7% upside vs current
Range: $52.00 — $72.00
Altman Z
10.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ROL buys
0
No recent congressional trades found for SYK or ROL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKROL
Forward yield1.04%1.38%
Annual dividend / share$3.40$0.73
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%100%
Portfolio after 10y$43.3K$14.17M
Annual income after 10y$8,282.98$12,435,164.79
Total dividends collected$21.0K$14.01M
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusBuyHold
Analyst price target$428.67$64.00

Year-by-year: SYK vs ROL ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrROL PortfolioROL Income/yrGap
1← crossover$10,852$152.43$10,975$275.26$123.00ROL
2$11,838$226.03$12,308$564.69$470.00ROL
3$13,004$336.89$14,353$1,183.69$1.3KROL
4$14,420$505.63$17,938$2,580.15$3.5KROL
5$16,195$766.09$25,221$6,027.23$9.0KROL
6$18,504$1,175.64$42,827$15,839.73$24.3KROL
7$21,635$1,835.40$96,098$50,273.53$74.5KROL
8$26,082$2,932.10$313,681$210,856.41$287.6KROL
9$32,737$4,829.68$1,622,132$1,286,493.33$1.59MROL
10$43,312$8,282.98$14,170,846$12,435,164.79$14.13MROL

SYK vs ROL: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ROLIndustrials

Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally. The company offers pest control services to residential properties protecting from common pests, including rodents, insects, and wildlife. It also provides workplace pest control solutions for customers across various end markets, such as healthcare, foodservice, and logistics. In addition, the company offers traditional and baiting termite protection, as well as ancillary services. It serves clients directly, as well as through franchisee operations. Rollins, Inc. was incorporated in 1948 and is headquartered in Atlanta, Georgia.

Full ROL Calculator →
📬

Get this SYK vs ROL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.